Gsp crop science limited IPO Overview
Gsp crop science limited IPO is a Mainboard public issue offered through a Book Building issue with a total issue size of ₹400 Cr. The IPO price band is set at ₹304 to ₹320 per share, and retail investors can apply with a minimum investment of ₹14,720 as per IPO guidelines.
The Gsp crop science limited IPO opens on 16 Mar 2026 and closes on 18 Mar 2026. The IPO allotment is expected to be finalized on 20 Mar 2026, and the equity shares are proposed to be listed on BSE, NSE on 24 Mar 2026.
Investors can refer to the Gsp crop science limited IPO RHP-DRHP for detailed information. The issue is managed by Equirus Capital Pvt.Ltd.,Motilal Oswal Investment Advisors Ltd. as the book running lead manager, while MUFG Intime India Private Limited (Link Intime) is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About gsp crop science limited
The company provides crop protection solutions to help farmers increase productivity, offering formulations (active ingredients and additives) and technicals (concentrated active ingredients) for effective pest, weed, and disease control.
The company offers a diverse portfolio of in-house manufactured agrochemicals, providing crop protection solutions through the development, manufacturing, supply, and distribution of Formulations and Technicals to meet customer needs.
The company have served customers spread across 20 states in India in the six months ended September 30, 2025 and Fiscals 2025, 2024 and 2023.
The company's international business is spread across 37 countries, including the United States of America, Uruguay, Brazil, Vietnam, Singapore, UAE and Australia during the six months ended September 30, 2025, Fiscals 2025, 2024 and 2023, including in Latin America, Asia Pacific (excluding India), North America and other geographies.
As of September 30, 2025 the company have received 524 registrations across Formulations and Technicals for agrochemicals. The company's research and development efforts over the years have led to being granted 102 patents, and also have 108 patent applications under process as of March 10, 2026.
The company invests in R&D to develop and improve Formulations and Technicals, with dedicated facilities in Kathwada and Odhav for testing, commercialization, and producing complex chemistries for the agrochemical market.
Business Operations:
Formulations: As of September 30, 2025, the company has 395 registrations for Formulations, composed of active ingredients and additives, available as solids or liquids, marketed under the company's brands or licenses.
Technicals: As of September 30, 2025, the company has 129 registrations for Technicals, which are concentrated active ingredients processed with other ingredients to create products like insecticides, herbicides, and fungicides.
As of September 30, 2025, the company has 1,221 permanent employees.
Competitive Strengths:
Well-diversified product portfolio including a wide range of insecticides, herbicides, fungicides, and plant growth regulators, making us a comprehensive solution provider for the customers.
Catering to a large and diverse clientele both domestically as well as internationally.
Strong in-house R&D capabilities with focus on innovation and product development
Robust manufacturing facilities with ability to manufacture a wide range of products with a focus on sustainability.
Led by qualified and experienced Promoters and supported by a professional management team
Investment Objective
General Corporate Purpose
Total
